The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly-skilled, diverse workforce that can conduct impactful clinical and translational research that improves health. Since the inception of MICHR, the development of a diverse translational workforce has been a consistent priority. The ?crown jewel? of our efforts has been the KL2 program, which has attracted and developed exceptional scholars. Since the inception of MICHR, KL2 scholars (n=36) have published >1,000 peer-reviewed publications (median=21) and received >$155M in grant support as principal investigators (>$4 million per scholar). Importantly, 97% of all KL2 graduates have remained in clinical and translational research and 85% of the 2006-2011 cohorts have been successfully promoted. We now propose to improve this program with enhanced leadership skills through a new Career Development Academy, career development tracking with electronic portfolios, formal mentorship training for KL2 mentors and scholars, expanded internship and externship opportunities, and a stronger network of support as our KL2 scholars transition to independence. MICHR?s goal is the creation of greater positive impact through training and mentoring a new generation of KL2 scholars.
| Prossin, Alan R; Chandler, Matthew; Ryan, Kelly A et al. (2018) Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorder. Psychoneuroendocrinology 89:194-202 |
| Haffajee, Rebecca L; Mello, Michelle M; Zhang, Fang et al. (2018) Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. Health Aff (Millwood) 37:964-974 |
| Sun, Yihan; Kim, Jae Hyun; Vangipuram, Kiran et al. (2018) Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy. Breast Cancer Res Treat 171:657-666 |
| Yang, Y Tony; Weintraub, Eric; Haffajee, Rebecca L (2018) Telemedicine's Role in Addressing the Opioid Epidemic. Mayo Clin Proc 93:1177-1180 |
| Carlozzi, Noelle E; Boileau, Nicholas R; Perlmutter, Joel S et al. (2018) Agreement between clinician-rated versus patient-reported outcomes in Huntington disease. J Neurol 265:1443-1453 |
| Thomson, Mary J; Lok, Anna S; Tapper, Elliot B (2018) Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes. Liver Int 38:1882-1890 |
| Tapper, Elliot B; Konerman, Monica; Murphy, Susan et al. (2018) Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 18:2566-2570 |
| Pérez-Matos, Maria Camila; Jiang, Z Gordon; Tapper, Elliot B (2018) Factors That Affect Results of Psychometric Tests to Identify Patients With Minimal Hepatic Encephalopathy. Clin Gastroenterol Hepatol 16:1836-1838 |
| Haffajee, Rebecca L; Bohnert, Amy S B; Lagisetty, Pooja A (2018) Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. Am J Prev Med 54:S230-S242 |
| Haffajee, Rebecca L; Frank, Richard G (2018) Making the Opioid Public Health Emergency Effective. JAMA Psychiatry 75:767-768 |
Showing the most recent 10 out of 24 publications
